Contact Information
Call us at: (614) 355-6867
Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Elizabeth A. Varga
Biography
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff. Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Awards, Honors & Organizations
Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019 Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019 Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015 Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015 Board of Directors, National Society of Genetic Counselors, 2018 - 2020
Research
Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Professional Experience
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development2017 - Present Institute for Genomic Medicine, Nationwide Children’s Hospital, Cancer Genomic Counselor2015 - Present Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Hem/Onc/BMT Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine2020 - 2021 Genomenon, Director of Customer Success2020 - 2020 PerkinElmer Genomics, Genomic Testing Consultant2010 - 2015 Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Genetic Counselor2006 - 2010 Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital, Research Coordinator/Genetic Counselor2004 - 2006 Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Genetic Counselor2002 - 2004 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Kansas Medical Center, Genetic Counselor
Contact Information
Institute for Genomic Medicine
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Connect with Elizabeth A. Varga
Connect on LinkedIn
Connect on Twitter
Contact Information
Call us at: (614) 355-6867
Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Elizabeth A. Varga
Biography
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff. Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Awards, Honors & Organizations
Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019 Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019 Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015 Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015 Board of Directors, National Society of Genetic Counselors, 2018 - 2020
Research
Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Professional Experience
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development2017 - Present Institute for Genomic Medicine, Nationwide Children’s Hospital, Cancer Genomic Counselor2015 - Present Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Hem/Onc/BMT Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine2020 - 2021 Genomenon, Director of Customer Success2020 - 2020 PerkinElmer Genomics, Genomic Testing Consultant2010 - 2015 Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Genetic Counselor2006 - 2010 Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital, Research Coordinator/Genetic Counselor2004 - 2006 Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Genetic Counselor2002 - 2004 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Kansas Medical Center, Genetic Counselor
Contact Information
Institute for Genomic Medicine
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Connect with Elizabeth A. Varga
Connect on LinkedIn
Connect on Twitter
Contact Information
Call us at: (614) 355-6867
Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Elizabeth A. Varga
Contact Information
- Call us at:
- (614) 355-6867
- Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Elizabeth A. Varga
Biography
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff. Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Biography
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff. Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Biography
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff. Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff. Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Elizabeth Varga, MS, CGC, is the director of Clinical Genomics Research and Development in the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and is a licensed genetic counselor and adjunct assistant professor of Pediatrics at The Ohio State University. She oversees development and implementation of genomic research protocols into various services lines across Nationwide Children’s and manages the Clinical Genomics research team comprised of genetic counselors, research coordinators and data/regulatory staff.
Elizabeth has almost 20 years of clinical experience as a genetic counselor, with specific expertise related to the genomics of pediatric hematologic, oncologic and immunologic disorders. She has served on the Board of Directors for the National Society of Genetic Counselors and was a founding Board member of the National Blood Clot Alliance.
See Elizabeth A. Varga’s Curriculum Vitae (CV)
Awards, Honors & Organizations
Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019 Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019 Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015 Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015 Board of Directors, National Society of Genetic Counselors, 2018 - 2020
Awards, Honors & Organizations
Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019 Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019 Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015 Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015 Board of Directors, National Society of Genetic Counselors, 2018 - 2020
Awards, Honors & Organizations
Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019 Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019 Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015 Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015 Board of Directors, National Society of Genetic Counselors, 2018 - 2020
Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019 Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019 Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015 Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015 Board of Directors, National Society of Genetic Counselors, 2018 - 2020
- Finalist - Code Talker Award in Genetic Counseling, Invitae/National Society of Genetic Counselors, 2019
- Outstanding Clinical Supervisor Award - Division of Genetic and Genomic Medicine, Nationwide Children’s Hospital, 2019
- Innovator of the Year Award, Nationwide Children’s Hospital Division of Hematology/Oncology/BMT, 2015
- Winner- CLARITY Undiagnosed (Genomics) Challenge, Team Member, Nationwide Children’s Hospital, 2015
- Board of Directors, National Society of Genetic Counselors, 2018 - 2020
Research
Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
Research
Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
Research
Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
View More Publications
- Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 Feb; 43: 247-270.
- Prince BT, Varga EA, McBride KL. Germline Variant Interpretation in Children with Severe Sepsis. J Clin Immunol. 2022 Oct 29;
- LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.
- Kraft MT, Pyle R, Dong X, Hagan JB, Varga E, van Hee M, Boyce TG, Pozos TC, Yilmaz-Demirdag Y, Bahna SL, Abraham RS. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. Clin Immunol. 2021 Aug; 229: 108788.
- Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. Eur J Med Genet. 2019 Jun 10; 103701.
- Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer. 2019 May 27; e27832.
- Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
Education
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Education
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Education
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Date of Appointment at Nationwide Children’s Hospital: 07/12/2006
Graduate School
University of Cincinnati
Date Completed: 06/15/2002
Undergraduate School
DePauw University
Date Completed: 05/30/2000
Professional Experience
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development2017 - Present Institute for Genomic Medicine, Nationwide Children’s Hospital, Cancer Genomic Counselor2015 - Present Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Hem/Onc/BMT Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine2020 - 2021 Genomenon, Director of Customer Success2020 - 2020 PerkinElmer Genomics, Genomic Testing Consultant2010 - 2015 Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Genetic Counselor2006 - 2010 Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital, Research Coordinator/Genetic Counselor2004 - 2006 Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Genetic Counselor2002 - 2004 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Kansas Medical Center, Genetic Counselor
Professional Experience
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development2017 - Present Institute for Genomic Medicine, Nationwide Children’s Hospital, Cancer Genomic Counselor2015 - Present Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Hem/Onc/BMT Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine2020 - 2021 Genomenon, Director of Customer Success2020 - 2020 PerkinElmer Genomics, Genomic Testing Consultant2010 - 2015 Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Genetic Counselor2006 - 2010 Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital, Research Coordinator/Genetic Counselor2004 - 2006 Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Genetic Counselor2002 - 2004 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Kansas Medical Center, Genetic Counselor
Professional Experience
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development2017 - Present Institute for Genomic Medicine, Nationwide Children’s Hospital, Cancer Genomic Counselor2015 - Present Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Hem/Onc/BMT Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine2020 - 2021 Genomenon, Director of Customer Success2020 - 2020 PerkinElmer Genomics, Genomic Testing Consultant2010 - 2015 Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Genetic Counselor2006 - 2010 Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital, Research Coordinator/Genetic Counselor2004 - 2006 Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Genetic Counselor2002 - 2004 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Kansas Medical Center, Genetic Counselor
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development2017 - Present Institute for Genomic Medicine, Nationwide Children’s Hospital, Cancer Genomic Counselor2015 - Present Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Hem/Onc/BMT Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine2020 - 2021 Genomenon, Director of Customer Success2020 - 2020 PerkinElmer Genomics, Genomic Testing Consultant2010 - 2015 Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Genetic Counselor2006 - 2010 Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital, Research Coordinator/Genetic Counselor2004 - 2006 Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Genetic Counselor2002 - 2004 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Kansas Medical Center, Genetic Counselor
2021 - Present Nationwide Children’s Hospital, Director of Clinical Genomics Research and Development
Contact Information
Institute for Genomic Medicine
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Contact Information
Institute for Genomic Medicine
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Contact Information
Institute for Genomic Medicine
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Institute for Genomic Medicine
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
Call us at: (614) 355-6867
575 Children’s CrossroadColumbus, OH 43215 (map)
- Call us at:
- (614) 355-6867
- 575 Children’s CrossroadColumbus, OH 43215 (map)
Connect with Elizabeth A. Varga
Connect on LinkedIn
Connect on Twitter
